Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Cindro Holding B V has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by a distinct examiner, SCOTLAND, REBECCA LYNN, within a distinct art unit. As the busiest examiner for this portfolio, SCOTLAND, REBECCA LYNN is responsible for the 1 pending office action. The presence of a distinct art unit for the pending action shows a singular focus for the company's current patent activities.
With only a single pending office action total, the prosecution footprint is currently limited to a single point of contact at the patent office. This structure means that the entirety of the company's pending biotechnology and pharmaceutical matters is concentrated under the review of SCOTLAND, REBECCA LYNN. This centralized approach allows the company to focus its resources on a specific technical challenge while navigating the examination process with one primary examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCOTLAND, REBECCA LYNN | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694864 | Stabilized Hydrogen Peroxide | SCOTLAND, REBECCA LYNN | 5d overdue |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694864 | Stabilized Hydrogen Peroxide | SCOTLAND, REBECCA LYNN | 1615 | §103§112 | Final Rejection | 5d overdue | Pending | Mar 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCindro Holding B V has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Rebecca Lynn Scotland has the most, with 1 of Cindro Holding B V's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.